Cargando…

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autores principales:	Kim, Hyung Yoon, Kim, Kye Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428948/ https://www.ncbi.nlm.nih.gov/pubmed/30808087 http://dx.doi.org/10.4070/kcj.2019.0023

Ejemplares similares

Acute Hemodynamic Changes after Single Administration of Udenafil in Pulmonary Arterial Hypertension: a Phase IIa Study
por: Chang, Sung-A, et al.
Publicado: (2018)

How to Determine Right Ventricular Dysfunction in Pulmonary Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2021)

Anterior Ischemic Optic Neuropathy Associated with Udenafil
por: Kim, In-Gun, et al.
Publicado: (2012)

Udenafil for the treatment of erectile dysfunction
por: Cho, Min Chul, et al.
Publicado: (2014)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Udenafil, a Phosphodiesterase 5 Inhibitor, Reduces Body Weight in High-Fat-Fed Mice
por: Ryu, Seong Yul, et al.
Publicado: (2018)

Concentration-dependent differential effects of udenafil on viability, proliferation, and apoptosis in vascular endothelial and smooth muscle cells
por: Fang, Cheng-Hu, et al.
Publicado: (2014)

A pilot study to explore the effect of udenafil on cerebral hemodynamics in older adults
por: Wang, Qi, et al.
Publicado: (2023)

Udenafil Induces the Hair Growth Effect of Adipose-Derived Stem Cells
por: Choi, Nahyun, et al.
Publicado: (2019)

The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
por: Özlülerden, Yusuf, et al.
Publicado: (2017)

Current Trends and Movements in Managing Pulmonary Arterial Hypertension in Korea
por: Seung, Jaeho, et al.
Publicado: (2023)

Chronic thromboembolic pulmonary hypertension: More options, more awareness
por: Allwood, B W, et al.
Publicado: (2023)

Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers
por: Kim, Yo Han, et al.
Publicado: (2015)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Transient Use of Oral Bosentan Can Be an Additional Option to Reduce Pulmonary Arterial Hypertension in a Patient with Severe Pulmonary Arterial Hypertension Associated with Atrial Septal Defect
por: Park, Yong Kyu, et al.
Publicado: (2011)

Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More
por: Kim, Young Dae
Publicado: (2011)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study
por: Lee, Tae Yoon, et al.
Publicado: (2015)

Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction
por: Park, Soon Hyun, et al.
Publicado: (2015)

Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension
por: Shimbo, Mai, et al.
Publicado: (2022)

Total Occlusion of Pulmonary Arteries by Embolization of Myxoma
por: Park, Hyukjin, et al.
Publicado: (2017)

Multimodality cardiovascular imaging in pulmonary embolism
por: Kim, Hyung Yoon, et al.
Publicado: (2021)

Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
por: Corris, Paul, et al.
Publicado: (2014)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension
por: Grinnan, Daniel, et al.
Publicado: (2019)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Borderline pulmonary pressures in scleroderma - a ‘pre-pulmonary arterial hypertension’ condition?
por: Kovacs, Gabor, et al.
Publicado: (2015)

Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension
por: Kim, Jun-Dae, et al.
Publicado: (2015)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension
por: Ayon, Ramon J., et al.
Publicado: (2023)

Therapeutic implications of microRNAs in pulmonary arterial hypertension
por: Lee, Aram, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_upahvmmvniabilvkihjv3pe1mk